How is the transaction price for the SiriusPoint (SPNT) share grant described?

The Form 4 reports a transaction price of $23.29 per Common Share for the 5,903-share grant. This figure is part of the standard disclosure and helps quantify the size of the compensation-related award granted to director Hudson Martin Peter on the reported transaction date.

SiriusPoint (SPNT) director receives 5,903-share equity grant, holds 9,601

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Hudson Martin Peter reported acquisition or exercise transactions in this Form 4 filing.

SiriusPoint Ltd director Hudson Martin Peter received an equity award of 5,903 Common Shares at $23.29 per share. This grant increases his direct holdings to 9,601 Common Shares. The total includes restricted shares scheduled to vest in full on May 30, 2027, contingent on his continued service as a director.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Hudson Martin Peter

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Shares	5,903	$23.29	$137K

Holdings After Transaction: Common Shares — 9,601 shares (Direct, null)

Footnotes (1)

Includes restricted shares that vest in full on May 30, 2027, subject to the Reporting Person's continued service as a director of the Company. Includes Restricted Shares.

Key Figures

Shares granted: 5,903 Common Shares Grant price: $23.29 per share Shares owned after transaction: 9,601 Common Shares +1 more

4 metrics

Shares granted 5,903 Common Shares Grant/award to director on May 29, 2026

Grant price $23.29 per share Price reported for the 5,903-share award

Shares owned after transaction 9,601 Common Shares Director’s direct holdings following the grant

Restricted share vesting date May 30, 2027 Restricted shares vest in full on this date

Key Terms

Common Shares, Restricted Shares, Grant, award, or other acquisition

3 terms

Common Shares financial

"security_title: Common Shares"

Common shares are the basic units of ownership in a company that give holders a claim on profits and a right to vote on key matters, like electing the board. Think of them as membership cards in a club: they let you share in successes and losses, but in a bankruptcy or liquidation they are paid after creditors and preferred shareholders, so their value can swing more and matters for assessing risk and potential return.

Restricted Shares financial

"Includes restricted shares that vest in full on May 30, 2027"

Restricted shares are company stock that cannot be sold or transferred immediately because they are subject to legal or contractual limits, such as a required holding period or performance conditions. They matter to investors because these locked-up shares can affect a company’s available stock for trading, future dilution, and insider incentives—imagine a gift that can’t be cashed until certain conditions are met, which changes when and how much supply can suddenly enter the market.

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

Form 4 Insider Transactions: What Each Field Means →

05/29/2026 - 04:41 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hudson Martin Peter

(Last)

(First)

(Middle)

POINT BUILDING

3 WATERLOO LANE

(Street)

PEMBROKE

HM08

(City)

(State)

(Zip)

BERMUDA

(Country)

2. Issuer Name and Ticker or Trading Symbol
SiriusPoint Ltd [ SPNT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/29/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Shares	05/29/2026		A		5,903⁽¹⁾	A	$23.29	9,601⁽²⁾	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Includes restricted shares that vest in full on May 30, 2027, subject to the Reporting Person's continued service as a director of the Company.

2. Includes Restricted Shares.

Remarks:

Exhibit 24-Power of Attorney

	/s/ Jacquelyne Belcastro, Attorney-in-Fact for Martin Hudson	05/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did SiriusPoint (SPNT) report in this Form 4?

SiriusPoint reported that director Hudson Martin Peter received a grant of 5,903 Common Shares at $23.29 per share. This was a compensation-related award rather than an open-market purchase or sale, and it increased his overall direct share ownership in the company.

How many SiriusPoint (SPNT) shares does the director hold after this grant?

After the grant, Hudson Martin Peter directly holds 9,601 Common Shares of SiriusPoint. This total includes restricted shares that are subject to vesting conditions, providing context for his overall equity stake following the reported Form 4 transaction.

Was the SiriusPoint (SPNT) Form 4 transaction a stock purchase or sale?

The Form 4 transaction was an acquisition through a grant or award, not a market purchase or sale. The filing classifies it under code A, indicating a grant, award, or other acquisition of 5,903 Common Shares as part of the director’s compensation arrangements.

What are the vesting terms of the restricted SiriusPoint (SPNT) shares?

The filing states that the director’s holdings include restricted shares that vest in full on May 30, 2027. Vesting is conditioned on Hudson Martin Peter’s continued service as a director of SiriusPoint, meaning he must remain on the board through that date.